1. 5PDPatritumab (anti-HER3 antibody) augments anti-tumor immune response of adoptive transfer of autologous activated T cells for patient-derived xenograft models of breast cancer. (23rd October 2018) Authors: Suzuki, E; Kotake, T; Nishimura, T; Yamaguchi, A; Pu, F; Toi, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗